Status:

UNKNOWN

Nonsurgical Reversible Obesity Treatment (NROT1)

Lead Sponsor:

Yeditepe University

Conditions:

Morbid Obesity

Eligibility:

All Genders

18-65 years

Phase:

NA

Brief Summary

The present study relates to apparatus and methods that can be applied using non-invasive techniques for effectively reducing nutrient absorption in the small intestines of obese people.

Detailed Description

Obesity is a worldwide health problem which may be further worsened by global Corona virus (COVID-19) pandemic. It may cause social, psychological disorders and chronic diseases such as diabetes and c...

Eligibility Criteria

Inclusion

  • Diagnosis of morbid obesity
  • Age limits: 18-65 years
  • No history of gastrointestinal surgery
  • Agreement for voluntary participation in the study

Exclusion

  • Presence of obesity that is not at the morbid level
  • Those who do not accept to participate in the study
  • Those who have an obstacle to endoscopic intervention
  • Presence of a history of gastrointestinal surgery

Key Trial Info

Start Date :

December 1 2022

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

June 1 2024

Estimated Enrollment :

20 Patients enrolled

Trial Details

Trial ID

NCT05420506

Start Date

December 1 2022

End Date

June 1 2024

Last Update

June 22 2022

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.

Nonsurgical Reversible Obesity Treatment (NROT1) | DecenTrialz